Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Combining ciclosporin and simvastatin can cause severe kidney damage.

An adult Libyan woman was successfully treated for a rare scalp infection usually seen in children.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The document's conclusion cannot be provided because the document is not readable or understandable.

Chemotherapy regimens were appropriate, but managing adverse effects like anemia and hair loss is crucial.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Long-term high-dose fluconazole can cause reversible hair loss.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Glioma treatment may improve with new therapies and technologies.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.